Weiss Multi-Strategy Advisers’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,600
Closed -$48K 755
2019
Q3
$48K Hold
5,600
﹤0.01% 563
2019
Q2
$75K Hold
5,600
﹤0.01% 479
2019
Q1
$89K Sell
5,600
-26
-0.5% -$396 ﹤0.01% 491
2018
Q4
$61K Hold
5,626
﹤0.01% 432
2018
Q3
$83K Buy
5,626
+18
+0.3% +$274 ﹤0.01% 498
2018
Q2
$82K Buy
5,608
+475
+9% +$6.68K ﹤0.01% 531
2018
Q1
$79K Sell
5,133
-200
-4% -$3.55K ﹤0.01% 514
2017
Q4
$106K Hold
5,333
﹤0.01% 537
2017
Q3
$108K Sell
5,333
-267
-5% -$5.71K ﹤0.01% 466
2017
Q2
$117K Sell
5,600
-67
-1% -$1.44K ﹤0.01% 500
2017
Q1
$119K Hold
5,667
﹤0.01% 526
2016
Q4
$92K Hold
5,667
﹤0.01% 394
2016
Q3
$127K Sell
5,667
-165
-3% -$3.8K 0.01% 402
2016
Q2
$108K Sell
5,832
-1,835
-24% -$48.8K 0.01% 390
2016
Q1
$201K Buy
7,667
+934
+14% +$29.1K 0.01% 428
2015
Q4
$244K Hold
6,733
0.02% 341
2015
Q3
$223K Buy
6,733
+2,066
+44% +$116K 0.01% 366
2015
Q2
$323K Hold
4,667
0.01% 399
2015
Q1
$351K Buy
+4,667
New +$367K 0.02% 387

Other funds holding ALIM

Weiss Multi-Strategy Advisers's ALIM Position: Q4 2019 in Review

Weiss Multi-Strategy Advisers sold out of Alimera Sciences (ALIM) in Q4 2019, closing a stake of 5,600 shares — an estimated $48K sold.

Weiss Multi-Strategy Advisers first reported a position in ALIM in Q1 2015 and held it in 19 quarters. The position peaked at $351K in Q1 2015. 22 funds tracked by Wall St. Rank hold ALIM as of Q4 2019.

  • Weiss Multi-Strategy Advisers reported no remaining Alimera Sciences position as of Q4 2019 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 5,600 Alimera Sciences shares in Q4 2019, an estimated $48K.
  • Weiss Multi-Strategy Advisers first reported a position in Alimera Sciences in Q1 2015 and held it in 19 quarters.
  • Weiss Multi-Strategy Advisers's Alimera Sciences position peaked at $351K in Q1 2015.
  • 22 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.